Search results
Results From The WOW.Com Content Network
In October 2015, Cinven took over the majority of shares of SYNLAB and merged both companies to become SYNLAB Group. [4] [7] Before, the private equity company BC Partners was the majority shareholder of SYNLAB. [8] In December 2016, Novo Holdings A/S acquired 10% of SYNLAB shares, which was increased to about 20% in 2017. [9]
Cinven Limited is a global private equity firm founded in 1977, with offices in nine international locations in Guernsey, London, New York, Paris, Frankfurt, Milan, Luxembourg, Madrid, and Hong Kong that acquires Europe and United States based corporations, and emerging market firms that fit with their core businesses, and necessitate a minimum equity investment of €100 million or more. [1]
Synnovis. Synnovis, formerly Viapath, is a London-based provider of pathology services. It is a partnership between Guy's and St Thomas' NHS Foundation Trust, King's College Hospital NHS Foundation Trust, and SYNLAB UK & Ireland. [1]
A leveraged buyout (LBO) is one company's acquisition of another company using a significant amount of borrowed money (leverage) to meet the cost of acquisition. The assets of the company being acquired are often used as collateral for the loans, along with the assets of the acquiring company. The use of debt, which normally has a lower cost of ...
July 18, 2024 at 3:15 PM. By Milana Vinn and Anirban Sen. (Reuters) -Smartsheet, a U.S. maker of workplace collaboration software with a market value of $6.6 billion, has tapped investment bankers ...
(Reuters) -The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences' liver disease treatment, Livdelzi, which it gained through a $4.3 billion buyout of CymaBay Therapeutics ...
Michael Wayland, CNBC. July 30, 2024 at 3:01 PM. Marco Bertorello. DETROIT — Automaker Stellantis plans to once again reduce its U.S. employee headcount through a broad voluntary buyout, as the ...
Pfizer. Allergan, plc. 160. 206. In November 2015 Pfizer announced it would acquire Allergan, plc for $160 billion ($206 billion, adjusted for inflation). However, this deal was cancelled in April 2016 due to new US tax inversion rules. [12][13] Had this transaction been completed, this would have been the largest within this industry. 2.